BIOSPECIFICS TECHNOLOGIES CORP License Agreements
7 Contracts & Agreements
- Second Amendment to Second Amended and Restated Development License Agreement, dated February 26, 2019, by and between the Company and Endo Global Ventures (Filed With SEC on February 28, 2019)
- First Amendment to Second Amended and Restated Development and License Agreement, by and between the Company and Endo Global Ventures, entered into as of February 1, 2016, with an... (Filed With SEC on February 5, 2016)
- Cellulite License Agreement dated August 23, 2007 between the Company and the Research Foundation (Filed With SEC on March 15, 2013)
- License Agreement dated March 27, 2010 between the Company and Zachary Gerut, M.D (Filed With SEC on March 15, 2013)
- Second Amended and Restated Development and License Agreement, dated as of August 31, 2011, by and between BioSpecifics Technologies Corp. and Auxilium Pharmaceuticals, Inc (Filed With SEC on September 1, 2011)
- Dupuytrens Disease License Agreement, dated November 21, 2006, between BioSpecifics Technologies Corp., and the Research Foundation of the State University of New York for and on... (Filed With SEC on November 28, 2006)
- Frozen Shoulder License Agreement, dated November 21, 2006, between BioSpecifics Technologies Corp., and the Research Foundation of the State University of New York for and on... (Filed With SEC on November 28, 2006)
